Bilin Cetinkaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bilin Cetinkaya has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ayşe Erbay
BAŞKENT ÜNİVERSİTESİ, TURGUT NOYAN UYGULAMA VE ARAŞTIRMA MERKEZİ
1 shared publication - Bermal Hasbay
BAŞKENT ÜNİVERSİTESİ, TURGUT NOYAN UYGULAMA VE ARAŞTIRMA MERKEZİ
1 shared publication Birgin Törer
Başkent Üniversitesi Tıp Fakültesi Pediatri AD, Yenidoğan Bilim Dalı
1 shared publication- Birgin Törer
Division of Neonatology, Department of Paediatrics, Baskent University Faculty of Medicine, Adana, Turkey; Department of Ophthalmology, Baskent University Faculty of Medicine, Ankara, Turkey
1 shared publication - Deniz Yilmaz
Pathology Department, Torbali State Hospital, Izmir, Turkey
1 shared publication - Elif Habibe Aktekin
Başkent üniversitesi adana dr. turgut noyan uygulama ve araştırma merkezi
1 shared publication
Latest Publications
- 6 November 2024
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 48 (1) , 104348
Predictive factors of early reactivation after ıntravitreal ranibizumab in agressive retinopathy of prematurity
- 6 November 2024
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 48 (1) , 104348
Predictive factors of early reactivation after ıntravitreal ranibizumab in agressive retinopathy of prematurity
- Open Access
- 29 May 2023
- Published by Akdeniz University in Akdeniz Medical Journal
- Vol. 10 (2) , 289-294
Differential Diagnosis And Management In Neonatal Mass Lesions: Ten Years Experience
Introduction: Neonatal tumors are rare and there is no standard approach to these diseases. Besides, cancer is an important cause of perinatal morbidity and mortality. The aim of this study is to analyze the incidence, clinical features and management of these exceptional tumors which were followed up at our center. Material and Method: We assessed all babies with solid masses admitted to our hospital between 2007-2018 retrospectively. The age, sex distribution, birth weight and gestational age, type of lesion, management and outcome were studied. Results: Of total; there were 62 cases over 10 years in which the most common solid neonatal tumor was germ cell tumor (30.6%). Forty two lesions were located in the abdomen. The majority of cases (48.3%) underwent only surgery for treatment strategy. Conclusion: In spite of limited management experience for newborn tumors, thanks to renovations in prenatal diagnostic methods and sufficient perinatal care, survival can be improved in specialised multidisciplinary centers.
- 29 May 2023
- Published by Akdeniz University in Akdeniz Medical Journal
- Vol. 10 (2) , 289-294
Open AccessDifferential Diagnosis And Management In Neonatal Mass Lesions: Ten Years Experience
Introduction: Neonatal tumors are rare and there is no standard approach to these diseases. Besides, cancer is an important cause of perinatal morbidity and mortality. The aim of this study is to analyze the incidence, clinical features and management of these exceptional tumors which were followed up at our center. Material and Method: We assessed all babies with solid masses admitted to our hospital between 2007-2018 retrospectively. The age, sex distribution, birth weight and gestational age, type of lesion, management and outcome were studied. Results: Of total; there were 62 cases over 10 years in which the most common solid neonatal tumor was germ cell tumor (30.6%). Forty two lesions were located in the abdomen. The majority of cases (48.3%) underwent only surgery for treatment strategy. Conclusion: In spite of limited management experience for newborn tumors, thanks to renovations in prenatal diagnostic methods and sufficient perinatal care, survival can be improved in specialised multidisciplinary centers.
- Open Access
- 29 December 2019
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 44 (4) , 1529-1531
İdiyopatik konjenital tek taraflı vokal kord paralizisi: yenidoğanda tekrarlayan pnömoni ataklarının nadir bir nedeni
- 29 December 2019
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 44 (4) , 1529-1531
Open Accessİdiyopatik konjenital tek taraflı vokal kord paralizisi: yenidoğanda tekrarlayan pnömoni ataklarının nadir bir nedeni
- 1 January 2003
- Published by Springer Nature in Biological Trace Element Research
- Vol. 94 (1) , 79-86
Effects of Iron(II) Salts and Iron(III) Complexes on Trace Element Status in Children with Iron-Deficiency Anemia
Iron-deficiency anemia (IDA) is the most common nutritional deficiency in childhood throughout the world. Although it has been shown that IRA is associated with elevated plasma copper and depleted zinc levels in children, there are conflicting results on the effect of iron supplementation on the absorption of these elements. The aim of this study was to investigate the effects of ferrous and ferric iron supplementation on the trace element status in children (n=25, aged 8–168 mo) with IDA. Fourteen of them were treated with ferric hydroxide-polymaltose complex (Ferrum, Vifor, Switzerland) (6 mg/d in the first 3 mo for initial therapy and 3 mg/kg for 3 mo as maintenance); the others were treated with a ferrous sulfate complex (FerroSanol, Schwarz, Germany) (6 mg/d in the first 3 mo for initial therapy and 3 mg/kg for 3 mo as maintenance). Plasma copper, zinc, and ceruloplasmin levels as well as hematological parameters were determined at baseline and the first, third, and sixth month of the treatment period. The hemoglobin and iron levels of patients in both groups were higher in the first and sixth months compared to baseline. Although the ceruloplasmin levels were depleted (48.9 mg/dL vs 41.4 mg/dL, p=0.035) during ferrous iron treatment, the copper and zinc levels remained unchanged. On the other hand, ferric iron supplementation led to an increase in zinc levels in the sixth month of treatment (0.77 mg/L vs 1.0 mg/L, p=0.021). The plasma copper levels were lower in the ferrous iron-treated group at the end of the first month of treatment than in the ferric irontreated group (1.06 mg/L vs 1.29 mg/L, p=0.008). In conclusion, our data showed that copper and ceruloplasmin metabolisms were affected by ferrous iron supplementation, whereas ferric iron kept them to normal levels of zinc, possibly by affecting their absorption. We conclude that the copper and zinc status of patients with IDA should be taken into consideration before and after iron therapy.
- 1 January 2003
- Published by Springer Nature in Biological Trace Element Research
- Vol. 94 (1) , 79-86
Effects of Iron(II) Salts and Iron(III) Complexes on Trace Element Status in Children with Iron-Deficiency Anemia
Iron-deficiency anemia (IDA) is the most common nutritional deficiency in childhood throughout the world. Although it has been shown that IRA is associated with elevated plasma copper and depleted zinc levels in children, there are conflicting results on the effect of iron supplementation on the absorption of these elements. The aim of this study was to investigate the effects of ferrous and ferric iron supplementation on the trace element status in children (n=25, aged 8–168 mo) with IDA. Fourteen of them were treated with ferric hydroxide-polymaltose complex (Ferrum, Vifor, Switzerland) (6 mg/d in the first 3 mo for initial therapy and 3 mg/kg for 3 mo as maintenance); the others were treated with a ferrous sulfate complex (FerroSanol, Schwarz, Germany) (6 mg/d in the first 3 mo for initial therapy and 3 mg/kg for 3 mo as maintenance). Plasma copper, zinc, and ceruloplasmin levels as well as hematological parameters were determined at baseline and the first, third, and sixth month of the treatment period. The hemoglobin and iron levels of patients in both groups were higher in the first and sixth months compared to baseline. Although the ceruloplasmin levels were depleted (48.9 mg/dL vs 41.4 mg/dL, p=0.035) during ferrous iron treatment, the copper and zinc levels remained unchanged. On the other hand, ferric iron supplementation led to an increase in zinc levels in the sixth month of treatment (0.77 mg/L vs 1.0 mg/L, p=0.021). The plasma copper levels were lower in the ferrous iron-treated group at the end of the first month of treatment than in the ferric irontreated group (1.06 mg/L vs 1.29 mg/L, p=0.008). In conclusion, our data showed that copper and ceruloplasmin metabolisms were affected by ferrous iron supplementation, whereas ferric iron kept them to normal levels of zinc, possibly by affecting their absorption. We conclude that the copper and zinc status of patients with IDA should be taken into consideration before and after iron therapy.